Independent register of U.S. FDA drug recalls · updated Oct 13, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,543 recalls, newest first.

Class II · Moderate risk

Infuvite PEDiatric Pharmacy

Defective Container: Sub-optimal crimping in vial of Pediatric Infuvite Multiple Vitamins

Terminated Packaging defect Sandoz, Inc NDC 54643-5647-0 D-1259-2020
Class II · Moderate risk

Lisinopril Tablets USP

Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.

Terminated Labeling / mix-up Lupin Pharmaceuticals Inc. NDC 68180-0981-03 D-1250-2020
Class II · Moderate risk

Nizatidine Oral Solution

CGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.

Terminated Nitrosamine impurity Amneal Pharmaceuticals of New York, LLC NDC 60846-301-15 D-1253-2020
Class II · Moderate risk

Estradiol

cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.

Terminated Particulate / foreign matter B & B Pharmaceuticals, Inc. NDC 63275-9900-8 D-1244-2020
Class II · Moderate risk

Levothyroxin

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1228-2020
Class II · Moderate risk

Bi-Est (8:2)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1218-2020
Class II · Moderate risk

Bi-Est (1:1)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1217-2020
Class II · Moderate risk

Bi-Est

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1216-2020
Class II · Moderate risk

Bi-Est (8:2)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1215-2020
Class II · Moderate risk

Bi-Est (50/50)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1214-2020
Class II · Moderate risk

Bi-Est (50/50)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1213-2020
Class II · Moderate risk

Bi-Est (1:1)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1212-2020

Recalls by year